11/09/2023
Vyriad Announces Oral Presentation at the 65th American Society of Hematology Annual Meeting
Read more:
/PRNewswire/ -- Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced that its...